Low Tigecycline Concentrations in the Cerebrospinal Fluid of a Neutropenic Patient with Inflamed Meninges

被引：22

作者：

Lengerke, Claudia ^{[1
]}

Haap, Michael ^{[2
]}

Mayer, Frank ^{[1
]}

Kanz, Lothar ^{[1
]}

Kinzig, Martina ^{[3
]}

Schumacher, Ulrike ^{[4
]}

Soergel, Fritz ^{[3
]}

Riessen, Reimer ^{[2
]}

机构：

[1] Univ Tubingen, Dept Oncol Hematol Immunol Rheumatol & Pneumol, Med Ctr 2, D-72074 Tubingen, Germany

[2] Univ Tubingen, Med Intens Care Unit, D-72074 Tubingen, Germany

[3] IBMP Inst Biomed & Pharmaceut Res, Nurnberg, Germany

[4] Univ Tubingen, Inst Microbiol, D-72074 Tubingen, Germany

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2011年 / 55卷 / 01期

关键词：

IN-VITRO ACTIVITY; RESISTANT;

D O I：

10.1128/AAC.00635-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：449 / 450

页数：2

共 11 条

[1] In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) [J].

Hoban, DJ ;

Bouchillon, SK ;

Johnson, BM ;

Johnson, JL ;

Dowzicky, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :215-227

[2] MULTIDRUG-RESISTANT ENTEROCOCCUS FAECIUM MENINGITIS IN A TODDLER CHARACTERIZATION OF THE ORGANISM AND SUCCESSFUL TREATMENT WITH INTRAVENTRICULAR DAPTOMYCIN AND INTRAVENOUS TIGECYCLINE [J].

Jaspan, Heather B. ;

Brothers, Adam W. ;

Campbell, Angela J. P. ;

McGuire, John K. ;

Browd, Samuel R. ;

Manley, Thomas J. ;

Pak, Daniel ;

Weissman, Scott J. .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (04) :379-381

[3] Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections [J].

Nau, Roland ;

Soergel, Fritz ;

Eiffert, Helmut .

CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (04) :858-+

[4] Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem [J].

Pachón-Ibáñez, ME ;

Jiménez-Mejías, ME ;

Pichardo, C ;

Llanos, AC ;

Pachón, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (11) :4479-4481

[5] Tigecycline [J].

Pankey, GA .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (03) :470-480

[6] In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay [J].

Pankey, George A. ;

Ashcraft, Deborah S. .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (03) :300-304

[7] Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose [J].

Rodvold, Keith A. ;

Gotfried, Mark H. ;

Cwik, Michael ;

Korth-Bradley, Joan M. ;

Dukart, Gary ;

Ellis-Grosse, Evelyn J. .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1221-1229

[8] Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis [J].

Tutuncu, E. Ediz ;

Kuscu, Ferit ;

Gurbuz, Yunus ;

Ozturk, Baris ;

Haykir, Asli ;

Sencan, Irfan .

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 :E224-E226

[9] Population pharmacokinetics of tigecycline in healthy volunteers [J].

Van Wart, S. A. ;

Cirincione, B. B. ;

Ludwig, E. A. ;

Meagher, A. K. ;

Korth-Bradley, J. M. ;

Owen, J. S. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (06) :727-737

[10]

Wadi JA, 2008, ANN SAUDI MED, V27, P456

← 1 2 →